Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × guadecitabine × Clear all

Phase

Status

Completed 12 Unknown 3 Active not recruiting 3 Terminated 2 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 513 Specimen Handling 422 Carboplatin 386 Magnetic Resonance Spectroscopy 378 Cisplatin 361 Cyclophosphamide 344 Radiotherapy 316 Gemcitabine 269 Bevacizumab 266 Paclitaxel 254 Biopsy 245 Drug Therapy 241 Blood Specimen Collection 215 venetoclax 202 fludarabine 200 Nivolumab 200 Capecitabine 194 Oxaliplatin 190 Docetaxel 185 Injections 179 Fluorouracil 169 Dexamethasone 159 Radiosurgery 157 Pemetrexed 140 Rituximab 138 Standard of Care 134 Surgical Procedures, Operative 131 durvalumab 128 atezolizumab 124 tislelizumab 120

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02998567 2025-08-17

HyPeR

Royal Marsden NHS Foundation Trust

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡